List of publications

All the publications of the C3M teams.

Export in CSV
The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance.

Authors Diazzi S, Tartare-Deckert S, Deckert M

Oncogenesis Feb 2023

IL-7 germline variant: setting the stage for immune-related adverse events.

Authors Issaoui H, Ricci JE

Molecular oncology Feb 2023

The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.

Authors Shoji KF, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A

EMBO reports Feb 2023

MCB-613 exploits a collateral sensitivity in drug resistant -mutant non-small cell lung cancer through covalent inhibition of KEAP1.

Authors Bassil CF, Anderson GR, Mayro B, Askin KN, Winter PS, Gruber S, Hall TM, Hoj JP, Cerda-Smith C, Hutchinson HM, Killarney ST, Singleton KR, Qin L, Jubien-Girard K, Favreau C, Martin AR, Robert G, Benhida R, Auberger P, Pendergast AM, Lonard DM, Puissant A, Wood KC

bioRxiv : the preprint server for biology Jan 2023

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.

Authors Aid Z, Robert E, Lopez CK, Bourgoin M, Boudia F, Le Mene M, Riviere J, Baille M, Benbarche S, Renou L, Fagnan A, Thirant C, Federici L, Touchard L, Lecluse Y, Jetten A, Geoerger B, Lapillonne H, Solary E, Gaudry M, Meshinchi S, Pflumio F, Auberger P, Lobry C, Petit A, Jacquel A, Mercher T

Leukemia Dec 2022

Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.

Authors Nazerai L, Willis SC, Yankilevich P, Di Leo L, Bosisio FM, Frias A, Bertolotto C, Nersting J, Thastrup M, Buus S, Thomsen AR, Nielsen M, Rohrberg KS, Schmiegelow K, De Zio D

Oncoimmunology Dec 2022

Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis.

Authors Ruetsch-Chelli C, Okuda DT, Rocher F, Tartare-Deckert S, Deckert M, Lebrun-Frenay C

Neurology and therapy Dec 2022

Editorial: Non-genetic adaptive drug resistance in cancer.

Authors Cerezo M, Sun X, Shen S

Frontiers in cell and developmental biology Dec 2022

Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.

Authors Calleja A, Loschi M, Bailly L, Morisot A, Marceau A, Mannone L, Robert G, Auberger P, Preudhomme C, Raynaud S, Subtil F, Sujobert P, Cluzeau T

Cancer medicine Nov 2022

BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.

Authors Delage L, Lambert M, Bardel E, Kundlacz C, Chartoire D, Conchon A, Peugnet AL, Gorka L, Auberger P, Jacquel A, Soussain C, Destaing O, Delecluse HJ, Delecluse S, Merabet S, Traverse-Glehen A, Salles GA, Bachy E, Billaud M, Ghesquieres H, Genestier L, Rouault JP, Sujobert P

Blood Nov 2022